31 Oct Ocriplasmin Approved for VMT and Macular Holes
[caption id="attachment_1191" align="alignleft" width="267"] Posterior Vitreous Detachment "Separates" from the Retinal Surface[/caption] Ocriplasmin, or Jetrea, has been FDA approved. The drug is approved only for a retinal condition called vitreomacular traction (VMT) or vitreomacular adhesion (VMA). The VMT may or may not be associated with a...